This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Elan Pharma International Limited. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Colleen Tsui Cutcliffe: Innovator in Parkin Activity Assays
Introduction
Colleen Tsui Cutcliffe is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the study of Parkin activity. Her innovative work has implications for understanding various biological processes and potential therapeutic applications.
Latest Patents
Colleen holds a patent for a groundbreaking invention titled "Parkin substrate and assay." This invention provides in vitro, ex vivo, and in vivo assays for Parkin activity, measuring Parkin-mediated ubiquitination of a Sept4 protein. The assays developed through this patent may be utilized to screen for agents that modulate Parkin protein ligase activity. This patent highlights her expertise and commitment to advancing scientific knowledge.
Career Highlights
Colleen is currently associated with Elan Pharma International Limited, where she continues to contribute to innovative research and development. Her work at the company reflects her dedication to improving healthcare through scientific advancements.
Collaborations
Colleen collaborates with Jennifer Johnston, a fellow professional in her field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving research goals.
Conclusion
Colleen Tsui Cutcliffe's contributions to the field of biotechnology, particularly through her patent on Parkin activity assays, underscore her role as a leading inventor. Her work not only enhances our understanding of biological mechanisms but also paves the way for future therapeutic developments.